The EBMT reposted this
Have you read our July issue yet? If you are looking for a place to start, check out this #OpenAccess publication that ISCT, International Society for Cell & Gene Therapy European Committee wrote in collaboration with The EBMT. The current challenges facing the translation of cell and gene therapies in Europe are explored, with recommendations on expanding registries for real-world assessment, the role of accreditation in protecting patients, and the importance of developing the sector's workforce are highlighted, among other key issues by Fermin Sanchez-Guijo, Joaquim Vives, Annalisa Ruggeri, Christian CHABANNON, Selim Corbacioglu, Harry Dolstra, Dominique FARGE, Nico Gagelmann, Claire Horgan, Jurgen Kuball, bénédicte Neven, Tuula Rintala, Vanderson Rocha, Isabel Sanchez-Ortega, Professor JOHN SNOWDEN, Jaap Jan Zwaginga, Massimiliano Gnecchi, Anna Sureda Balari. https://lnkd.in/geRErgZZ
Research and Development of Advanced Therapies
2moA shared view from ISCT, International Society for Cell & Gene Therapy Europe and The EBMT. It’s great to read it now in its final format in Cytotherapy.